Back

We need to add a risk score to hs-troponin - CONTRA.

3 March 2019 (09:42 - 09:54)
Organised by:
Congress Presentation Part of: Controversies in diagnostic strategies for chest pain patients Biomarkers ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Professor Jasper Boeddinghaus

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
hs-troponin should be used in unselected patients with suspected ACS. PRO.
Professor B. Lindahl (Uppsala, SE)
Slides
Presentation thumbnail
hs-troponin should be used in unselected patients with suspected ACS. CONTRA.
Professor M. Moeckel (Berlin, DE)
Slides Video
Presentation thumbnail
hs-troponin should be used in unselected patients with suspected ACS. Discussion.
Presentation thumbnail
We need to add a risk score to hs-troponin - PRO.
Doctor M. Tubaro (Rome, IT)
Slides Video
Presentation thumbnail
We need to add a risk score to hs-troponin - Discussion.

Access the full session

Session thumbnail
Controversies in diagnostic strategies for chest pain patients

The Event

Event poster

Acute Cardiovascular Care 2019

3 March 2019 09:42 CET
You may be interested in
thumbnail
Congress Presentation
Rethinking risk stratification in acute chest pain: limited value of HEAR and GRACE scores in the high-sensitivity troponin era from a brazilian cohort
20 March 2026
thumbnail
Congress Session
Great Debate: the calcium score is essential in cardiovascular disease risk assessment
29 August 2022
thumbnail
Webinar
ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation
24 November 2021
thumbnail
Congress Presentation
Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources